MGX analyst estimates
Metagenomi Therapeutics (MGX) analyst ratings, the average price target and its range, and every firm's latest call.
- 2 firms rate MGX: 2 buy, 0 hold, 0 sell.
- The average price target is $14.50 from None analysts, from $7.00 to $22.00.